Stannous methanesulfonate, a tin‑based organometallic compound, is widely employed as an active pharmaceutical ingredient, a preservative in cosmetics, and a catalyst in specialty industrial formulations. Its multifunctional profile makes it a strategic raw material for anti‑ulcer drugs, skin‑care products, and niche chemical processes. The Stannous Methanesulfonate market size was valued at approximately USD 70 million in 2025, and industry analysts project a growth outlook with a CAGR of about 3.5% from 2026 to 2033, driving the market forecast toward USD 98 million by 2033. This industry expansion reflects rising demand in pharmaceutical therapeutics, heightened consumer awareness of skin health, and steady supply‑chain investments in tin‑based chemistries.